1. Home
  2. GRFS vs BROS Comparison

GRFS vs BROS Comparison

Compare GRFS & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • BROS
  • Stock Information
  • Founded
  • GRFS 1940
  • BROS 1992
  • Country
  • GRFS Spain
  • BROS United States
  • Employees
  • GRFS N/A
  • BROS N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • BROS Restaurants
  • Sector
  • GRFS Health Care
  • BROS Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • BROS Nasdaq
  • Market Cap
  • GRFS 6.0B
  • BROS 5.4B
  • IPO Year
  • GRFS 2006
  • BROS 2021
  • Fundamental
  • Price
  • GRFS $9.45
  • BROS $46.60
  • Analyst Decision
  • GRFS Sell
  • BROS Buy
  • Analyst Count
  • GRFS 2
  • BROS 10
  • Target Price
  • GRFS $10.50
  • BROS $47.30
  • AVG Volume (30 Days)
  • GRFS 1.0M
  • BROS 3.8M
  • Earning Date
  • GRFS 01-01-0001
  • BROS 11-06-2024
  • Dividend Yield
  • GRFS N/A
  • BROS N/A
  • EPS Growth
  • GRFS N/A
  • BROS 711.34
  • EPS
  • GRFS 0.27
  • BROS 0.32
  • Revenue
  • GRFS $7,814,096,584.00
  • BROS $1,192,352,000.00
  • Revenue This Year
  • GRFS $8.86
  • BROS $32.64
  • Revenue Next Year
  • GRFS $7.00
  • BROS $20.69
  • P/E Ratio
  • GRFS $41.33
  • BROS $144.39
  • Revenue Growth
  • GRFS 7.21
  • BROS 30.53
  • 52 Week Low
  • GRFS $5.30
  • BROS $25.46
  • 52 Week High
  • GRFS $12.15
  • BROS $50.24
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 62.73
  • BROS 74.57
  • Support Level
  • GRFS $8.69
  • BROS $32.68
  • Resistance Level
  • GRFS $9.75
  • BROS $49.50
  • Average True Range (ATR)
  • GRFS 0.37
  • BROS 1.92
  • MACD
  • GRFS 0.06
  • BROS 1.15
  • Stochastic Oscillator
  • GRFS 80.27
  • BROS 79.27

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About BROS Dutch Bros Inc.

Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments company-operated shops and franchising and other.

Share on Social Networks: